Israel - Press Releases

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Bruce Townshend, chief of employer engagement at the Defense Department's Employer Support of the Guard & Reserve (ESGR) Office, will deliver the keynote address at the nation's premier veteran employment event, the Spring 2025 Employing U.S. Vets Conference, VETS Indexes is pleased to announce. Townshend will headline a dynamic group of speakers and panelists on April 10, 2025, in New York City for the conference, now in its 12th season. Tickets are available now, with virtual tickets also available for those who cannot attend in person.

SAN FRANCISCO, 20 de febrero de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Rouda Feder Tietjen & McGuinn aborda las complejidades del sistema de negligencia comparativa de California y ofrece orientacin estratgica para abogados de lesiones personales. California opera bajo un sistema de "negligencia comparativa pura", lo que significa que la compensacin de un demandante se reduce proporcionalmente a su grado de culpa. Por ejemplo, una indemnizacin de $ 100.000 podra reducirse a $ 60.000 si el demandante es considerado responsable en un 40%. Este sistema, aunque apunta a la equidad, requiere una cuidadosa consideracin de las acciones del demandante.

SAN FRANCISCO, Feb. 20, 2025 /PRNewswire/ -- Rouda Feder Tietjen & McGuinn addresses the complexities of California's comparative negligence system and offers strategic guidance for personal injury attorneys. California operates under a "pure comparative negligence" system, meaning a plaintiff's compensation is reduced proportionally to their degree of fault. For instance, a $100,000 award could be lowered to $60,000 if the plaintiff is deemed 40% responsible. This system, while aiming for fairness, necessitates careful consideration of the plaintiff's actions.

2025220 // -- Rouda Feder Tietjen & McGuinn 40% 100,000 60,000

2025220 // -- Rouda Feder Tietjen & McGuinn "" 40 100,00060,000

Fullerton Mayor Fred Jung and Paso Robles Councilmember Fred Strong to Lead the Agency's Board of Directors

Featuring Influential Business Leaders, Media Trailblazers, and Political Powerhouses

March 1, 2025, at The Meadows School

CALGARY, Alberta, 20 de febrero de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Parkland Corporation ("Parkland", "nosotros", la "compaa" o "nuestro") (TSX: PKI) espera anunciar sus resultados del cuarto trimestre de 2024 y del cierre del ao despus del cierre de los mercados el mircoles 5 de marzo de 2025. A continuacin, se celebrar una conferencia telefnica y transmisin por Internet a las 6:30 a.m. MT (8:30 a. m. hora del este) el jueves, 6 de marzo de 2025, para analizar los resultados.

El alcalde de Fullerton, Fred Jung, y el concejal de Paso Robles, Fred Strong, liderarn la junta directiva de la agencia

SAN DIEGO, Feb. 20, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Neumora Therapeutics, Inc. (NASDAQ: NMRA) common stock pursuant and/or traceable to Neumora's registration statement issued in connection with Neumora's initial public offering (the "IPO") held on September 15, 2023, have until April 7, 2025 to seek appointment as lead plaintiff of the Neumora class action lawsuit. Captioned Chang v. Neumora Therapeutics, Inc., No. 25-cv-01072, and pending it the Southern District of New York, the Neumora class action lawsuit charges Neumora as well as certain of Neumora's top executives and directors, and certain underwriters of the IPO, with violations of the Securities Act of 1933.

BROOKLYN, N.Y., Feb. 20, 2025 /PRNewswire/ -- On or about September 19, 2024, Atlantis Operating LLC d/b/a The Phoenix Rehabilitation and Nursing Center ('Phoenix') learned of a data security incident involving a third party vendor, which may have impacted the personal information of current and/or past patients of Phoenix. Phoenix has since diligently worked to determine what happened and what information was involved as a result of this incident. Phoenix, consistent with industry standards, promptly launched an investigation and engaged experts to assist in assessing the scope of the incident. Based on information provided by the third party, it was determined the incident occurred between on or about July 20, 2024. Upon identification of the potentially impacted data set, efforts were then initiated to provide notice to the potentially impacted population.

Canada's Leading Medical Cannabis Company Broadens Innovative Product Portfolio to Growing Market in Australia

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination. The market growth is largely fueled by the increasing uptake of the influenza vaccine and government efforts to raise awareness and encourage vaccination.

Enhanced Women's Health Program Integrates Pelvic Floor Therapy and Menopause Care Through Partnership with Vira Health

FREMONT, Calif., Feb. 20, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of its Certified Service Provider (CSP) Program, designed to expand access to its cutting-edge NULISA assays in academia and biopharmaceutical research.

WINDHAM, N.H., Feb. 20, 2025 /PRNewswire/ --The United States is projected to face a shortage of up to 8,650 cardiologists by 2037, raising serious concerns about access to cardiovascular care. To help healthcare leaders navigate the growing workforce challenge, Medicus Healthcare Solutions has released a new white paper titled An Inside Look at the Cardiology Workforce: Shortages, Demand, and Strategic Responses.

HONG KONG, Feb. 20, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced the company has successfully enrolled the first patient in itsmulticenter, randomized, double-blind Phase III clinical trial of ivonescimab in combination with chemotherapy for first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) (HARMONi-BC1/AK112-308). Ivonescimab is a first-in-class PD-1/VEGF bispecific antibody independently developed by the company.

Auf dem 25. Wellness Congress stellte Nerio Alessandri in Anwesenheit von 2.000 Menschen aus 100 Lndern Healthness vor, die neue Vision, die die Zukunft von Wellness und Prvention revolutionieren wird.

LUND,Sweden, Feb. 21, 2025 /PRNewswire/ --Immunovia will publish its full year 2024 results on February 25, 2025 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com.

SEGUIN, Texas, Feb. 20, 2025 /PRNewswire/ -- Alamo Group Inc. (NYSE: ALG) today announced that it will release its fourth quarter and year-end financial results after the market closes on Thursday, February 27, 2025. The Company will host a conference call to discuss the results on Friday, February 28, 2025, at 10:00 a.m. ET. Hosting the call will be members of senior management.

Teamsters Demand Employer Negotiate in Good Faith for Fair First Contract

Kenwood Investments to Build Bay Area's First New Bay Area Marina in Nearly 25 Years After Winning BCDC Approval

Three builders launched home sales, selling 13 homes in one month, and construction has started on more than half the homes in Phase 1.

LANCASTER, Pa., Feb. 20, 2025 /PRNewswire/ -- Burnham Holdings, Inc. (OTC-Pink: BURCA) ("BHI", the "Company", "we" or "our") today reported its consolidated financial results for the fourth quarter and full year of 2024, setting new all-time highs in net sales, net income and earnings per share. Where noted, prior periods presented have been restated for a voluntary change in accounting principle related to our last-in, first-out (LIFO) inventory valuation as disclosed in our 2023 Annual Report.